Callahan Advisors, LLC Merck & Co., Inc. Transaction History

Callahan Advisors, LLC

$986 Million
Q3 2024

A detailed history of Callahan Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Callahan Advisors, LLC holds 30,085 shares of MRK stock, worth $2.99 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

30,085

Previous 30,178 0.31%

Holding current value

$2.99 Million

Previous $3.74 Million 8.57%

% of portfolio

0.35%

Previous 0.4%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$111.15 - $128.97 $10,336 - $11,994	-93 Reduced 0.31%	30,085 $3.42 Million
Q2 2024 Jul 29, 2024	SELL	$123.8 - $132.96 $50,758 - $54,513	-410 Reduced 1.34%	30,178 $3.74 Million
Q1 2024 Apr 24, 2024	BUY	$113.24 - $131.95 $792 - $923	7 Added 0.02%	30,588 $4.04 Million
Q4 2023 Jan 24, 2024	BUY	$100.18 - $109.02 $801 - $872	8 Added 0.03%	30,581 $3.33 Million
Q3 2023 Oct 23, 2023	BUY	$102.95 - $114.33 $162,352 - $180,298	1,577 Added 5.44%	30,573 $3.15 Million
Q2 2023 Jul 31, 2023	SELL	$108.61 - $118.38 $35,624 - $38,828	-328 Reduced 1.12%	28,996 $3.35 Million
Q1 2023 Apr 28, 2023	BUY	$102.94 - $114.86 $823 - $918	8 Added 0.03%	29,324 $3.12 Million
Q4 2022 Feb 03, 2023	BUY	$87.44 - $112.11 $786 - $1,008	9 Added 0.03%	29,316 $3.25 Million
Q3 2022 Oct 27, 2022	SELL	$84.53 - $94.96 $169 - $189	-2 Reduced 0.01%	29,307 $2.52 Million
Q2 2022 Jul 29, 2022	SELL	$83.49 - $94.64 $918 - $1,041	-11 Reduced 0.04%	29,309 $2.67 Million
Q1 2022 Apr 27, 2022	BUY	$73.51 - $82.4 $284,630 - $319,052	3,872 Added 15.22%	29,320 $2.41 Million
Q4 2021 Feb 08, 2022	BUY	$72.28 - $90.54 $145,210 - $181,894	2,009 Added 8.57%	25,448 $1.95 Million
Q3 2021 Nov 03, 2021	BUY	$71.68 - $78.83 $1.29 Million - $1.41 Million	17,931 Added 325.54%	23,439 $1.76 Million
Q2 2021 Aug 11, 2021	BUY	$70.31 - $77.77 $130,354 - $144,185	1,854 Added 50.74%	5,508 $428,000
Q1 2021 Apr 21, 2021	BUY	$68.86 - $81.11 $619 - $729	9 Added 0.25%	3,654 $282,000
Q4 2020 Jan 20, 2021	SELL	$71.77 - $79.65 $8,397 - $9,319	-117 Reduced 3.11%	3,645 $298,000
Q3 2020 Oct 26, 2020	BUY	$73.18 - $82.95 $22,612 - $25,631	309 Added 8.95%	3,762 $312,000
Q2 2020 Jul 17, 2020	SELL	$70.42 - $80.13 $13,309 - $15,144	-189 Reduced 5.19%	3,453 $267,000
Q1 2020 Apr 06, 2020	BUY	$63.36 - $87.82 $1,457 - $2,019	23 Added 0.64%	3,642 $280,000
Q4 2019 Jan 21, 2020	BUY	$77.58 - $87.54 $1,939 - $2,188	25 Added 0.7%	3,619 $329,000
Q3 2019 Oct 21, 2019	BUY	$76.08 - $82.93 $532 - $580	7 Added 0.2%	3,594 $303,000
Q2 2019 Jul 17, 2019	BUY	$69.84 - $81.59 $488 - $571	7 Added 0.2%	3,587 $301,000
Q1 2019 Apr 22, 2019	BUY	$69.58 - $79.36 $58,586 - $66,821	842 Added 30.75%	3,580 $298,000
Q4 2018 Jan 24, 2019	BUY	$65.24 - $75.71 $178,627 - $207,293	2,738 New	2,738 $209,000
Q4 2017 Jan 31, 2018	SELL	$51.62 - $61.64 $187,277 - $223,629	-3,628 Closed	0 $0
Q3 2017 Oct 26, 2017	BUY	$58.67 - $63.13 $212,854 - $229,035	3,628	3,628 $232,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Callahan Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Callahan Advisors, LLC with notifications on news.

Account

Callahan Advisors, LLC Merck & Co., Inc. Transaction History